Get Premium Data for Cyber Monday: Up to 55% Off InvestingProCLAIM SALE

Prestige Consumer Healthcare Inc (PBH)

NYSE
Currency in USD
84.33
-1.35(-1.58%)
Closed
After Hours
84.33+0.12(+0.14%)
PBH Scorecard
Full Analysis
5 analysts have revised their earnings downwards for the upcoming period
Fair Value
Day's Range
83.9686.07
52 wk Range
57.9586.36
Key Statistics
Edit
Prev. Close
85.68
Open
86.07
Day's Range
83.96-86.07
52 wk Range
57.95-86.36
Volume
202.7K
Average Vol. (3m)
258.94K
1-Year Change
40.65%
Book Value / Share
unlockUnlock
Fair Value
unlockUnlock
Fair Value Upside
unlockUnlock
PBH Scorecardpro icon
Company’s Health
pro lockUnlock
Fair Value
pro lockUnlock Price
Fair Pricepro lock
Upsidepro lock
Price Target
85.29
Upside
+1.14%
Members' Sentiments
Bearish
Bullish
ProTips
Stock generally trades with low price volatility
Show more

Prestige Consumer Healthcare Inc Company Profile

Prestige Consumer Healthcare Inc., together with its subsidiaries, develops, manufactures, markets, distributes, and sells over the counter (OTC) health and personal care products in North America, Australia, and internationally. The company operates in two segments, North American OTC Healthcare and International OTC Healthcare. It offers analgesic powders under the BC and Goody's brand; diaper rash treatments and skin protectants for babies under the Boudreaux's Butt Paste brand name; sprays and lozenges to relieve sore throats and mouth pain under the Chloraseptic brand; eye care products that provide relief from redness and itchiness under the Clear Eyes brand name; at-home removal of common and plantar warts under the Compound W brand; and Debrox for ear wax removal. The company also provides dental guards, floss picks, interdental brushes, dental repair and kits, and tongue cleaners under the DenTek brand; Dramamine for motion sickness relief; enemas and other laxative products under the Fleet brand name; Gaviscon for upset stomach; cough drops under the Luden's brand; Monistat for yeast infections in women; Nix for lice and parasite treatments; feminine care products, including washes, cloths, and sprays under the Summer's Eve brand; TheraTears for dry eyes; nasal saline sprays and washes under the Fess brand name; and Hydralyte for oral rehydration. It sells its products through mass merchandisers; and drug, food, dollar, convenience, and club stores, as well as e-commerce channels. The company was formerly known as Prestige Brands Holdings, Inc. and changed its name to Prestige Consumer Healthcare Inc. in August 2018. Prestige Consumer Healthcare Inc. was founded in 1996 and is headquartered in Tarrytown, New York.

Employees
560

Compare PBH to Peers and Sector

Metrics to compare
PBH
Peers
Sector
Relationship
P/E Ratio
20.2x−4.8x−0.6x
PEG Ratio
0.060.020.00
Price / Book
2.4x0.9x2.6x
Price / LTM Sales
3.8x1.2x3.2x
Upside (Analyst Target)
3.2%131.5%44.6%
Fair Value Upside
Unlock13.6%7.3%Unlock

Analysts' Recommendations

5 Buy
2 Hold
1 Sell
Ratings:
7 analysts
Overall Consensus
Buy

Analysts 12-Month Price Target:

Average 85.29

(+1.13% Upside)

People Also Watch

72.62
OGS
-1.92%
25.700
SMR
+5.54%
11.85
OI
-0.42%
105.03
CBT
+1.32%
107.21
CHD
-1.79%

FAQ

What Is the Prestige Consumer Health (PBH) Stock Price Today?

The Prestige Consumer Health stock price today is 84.33

What Stock Exchange Does Prestige Consumer Health Trade On?

Prestige Consumer Health is listed and trades on the NYSE stock exchange.

What Is the Stock Symbol for Prestige Consumer Health?

The stock symbol for Prestige Consumer Health is "PBH."

What Is the Prestige Consumer Health Market Cap?

As of today, Prestige Consumer Health market cap is 4.17B.

What is Prestige Consumer Health Earnings Per Share?

The Prestige Consumer Health EPS is 4.14.

What Is the Next Prestige Consumer Health Earnings Date?

Prestige Consumer Health will release its next earnings report on Feb 06, 2025.

From a Technical Analysis Perspective, Is PBH a Buy or Sell?

Based on moving averages and other technical indicators, the daily buy/sell signal is Strong Buy.
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2024 - Fusion Media Limited. All Rights Reserved.